Literature DB >> 1362363

Erythromycin base-induced rash and liver function disturbances.

H Shirin1, J M Schapiro, N Arber, J Pinkhas, Y Sidi, F Salomon.   

Abstract

OBJECTIVE: To report a case of erythromycin base-induced rash and liver function disturbances. CASE
SUMMARY: A patient with erythema nodosum and high antistreptolysin-O titers was treated with erythromycin on the assumption that occult streptococcal infection was the cause of the erythema nodosum. Forty-eight hours after the initiation of therapy the patient developed fever, severe generalized rash, pruritus, and cholestatic and hepatocellular liver function disturbances. Extensive evaluation to determine the cause of liver function disturbances was unrevealing. Marked improvement was noticed within days after cessation of erythromycin. DISCUSSION: Case reports in the literature on the adverse effects of erythromycin and its derivatives were reviewed. The possible immunologic mechanism involved is postulated.
CONCLUSIONS: Erythromycin base must be added to the list of erythromycin derivatives that can cause rash and liver function disturbances. The concomitant appearance of fever, rash, jaundice, and liver function disturbances raises the possibility of hypersensitivity as the mechanism for the liver disturbances.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362363     DOI: 10.1177/106002809202601207

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  2 in total

1.  1H NMR-based serum metabolomics reveals erythromycin-induced liver toxicity in albino Wistar rats.

Authors:  Atul Rawat; Durgesh Dubey; Anupam Guleria; Umesh Kumar; Amit K Keshari; Swati Chaturvedi; Anand Prakash; Sudipta Saha; Dinesh Kumar
Journal:  J Pharm Bioallied Sci       Date:  2016 Oct-Dec

Review 2.  Macrolide Allergic Reactions.

Authors:  Kristy M Shaeer; Elias B Chahine; Sheeba Varghese Gupta; Jonathan C Cho
Journal:  Pharmacy (Basel)       Date:  2019-09-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.